326
Views
23
CrossRef citations to date
0
Altmetric
Letters to the Editor

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

, , , , , , & show all
Pages 718-720 | Received 21 Jul 2011, Accepted 09 Sep 2011, Published online: 27 Apr 2012
 

Acknowledgements

This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, M.D., Chair) and supported in part by Public Health Service Grants CA21115, CA23318, CA66636, CA21076, CA16116, CA13650 and from the National Cancer Institute, National Institutes of Health and the Department of Health and Human Services.

Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.